DRKS00032481招募中不适用
Investigation of the gut microbiome in patients with head and neck cancer (HNSCC) and analysis of the prognostic potential of response and tolerability of PD-1, PDL-1 immune checkpoint inhibitors in head and neck cancer
ehrstuhl für Hals-Nasen-Ohrenheilkunde Universität Witten/Herdecke0 个研究点目标入组 50 人开始时间: 2023年9月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Histologically confirmed head and neck carcinoma for which immune checkpoint inhibitor therapy (PD-1, PD-L1) is planned as part of treatment
排除标准
- •Age under 18, lack of capacity to consent, and lack of patient consent
研究者
相似试验
招募中
不适用
Characterization of gut microbiome in patients with lung adenocarcinomalung adenocarcinomaJPRN-UMIN000040543Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine50
进行中（未招募）
Unknown
Evaluation of the pattern of gut bacteria in patients with type 2 Diabetes Mellitus using the drug SemaglutideType 2 Diabetes MellitusRBR-5xhygvdniversidade Estadual de Campinas
已完成
不适用
Alterations of the gut microbiome in patients with IBS in correlation to illness anxiety and symptom severityK58F45.32Irritable bowel syndromeDRKS00033141niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik70
已完成
不适用
Study of the involvement of the gut microbiota in the pathophysiology and treatment effect of patients with unresectable hepatocellular carcinoma.Hepatocellular carcinomaJPRN-UMIN000042709Kurume university60
已完成
不适用
Analysis of gut microbiota in patients with neuromuscular syndromes compared to control-groupsG70.0G70.8Other specified myoneural disordersMyasthenia gravisDRKS00017134Klinik für Neurologie, Universitätsmedizin Essen76